iclusig
incyte biosciences distribution b.v. - ponatinib - leukemia, myeloid; leukemia, lymphoid - antineoplastic agents, protein kinase inhibitors - iclusig is indicated in adult patients withchronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (cml) who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutationphiladelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) who are resistant to dasatinib; who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutation. ver secciones 4. 2 assessment of cardiovascular status prior to start of therapy and 4. 4 situations where an alternative treatment may be considered.
etersa 100 mg tabletas recubiertas
laboratorios synthesis s.a.s. colombia - dasatinib 100 mg - tableta recubierta - cada tableta recubierta contiene: dasatinib monohidrato 103.69 mg equivalente a dasatinib 100 mg
etersa 70 mg tabletas recubiertas
laboratorios synthesis s.a.s. colombia - dasatinib 70 mg - tableta recubierta - cada tableta recubierta contiene: dasatinib monohidrato equivalente a dasatinib 70 mg
fontrax
s richmond s.a.c.i.f. - dasatinib - comprimidos recubiertos - dasatinib (como monohidrato) 50 mg
sprytinib 100
dosa s.a. - dasatinib - comprimidos recubiertos - dasatinib (como monohidrato) 100 mg
sprytinib 20
dosa s.a. - dasatinib - comprimidos recubiertos - dasatinib (como monohidrato) 20 mg
sprytinib 50
dosa s.a. - dasatinib - comprimidos recubiertos - dasatinib (como monohidrato) 50 mg
sprytinib 70
dosa s.a. - dasatinib - comprimidos recubiertos - dasatinib (como monohidrato) 70 mg
liteda 100 mg comprimido recubierto
tecnofarma s.a. - dasatinib; - comprimido recubierto - por comprimido - otros agentes antineoplÁsicos
liteda 50mg comprimido recubierto
tecnofarma s.a. - dasatinib; - comprimido recubierto - por comprimido - otros agentes antineoplÁsicos